Adipose-derived mesenchymal stromal cells for chronic myocardial ischemia (MyStromalCell Trial): Study design

Regenerative Medicine

Volumn 7, Issue 3, 2012, Pages 421-428

  Qayyum, Abbas Ali ^a   Haack Sørensen, Mandana ^a   Mathiasen, Anders Bruun ^a   Jørgensen, Erik ^a   Ekblond, Annette ^a   Kastrup, Jens ^a  

^a Rigshospitalet   (Denmark)

Author keywords

adipose tissue; adipose derived stromal cell; cardiac repair; chronic ischemic heart disease; double blind; intramyocardial injection; mesenchymal stem cell; mesenchymal stromal cell; MyStromalCell Trial; placebo controlled trial; randomized; vascular endothelial growth factor

Indexed keywords

5' NUCLEOTIDASE; ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; ALPHA5 INTEGRIN; BETA1 INTEGRIN; CD51 ANTIGEN; ENDOGLIN; HERMES ANTIGEN; HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; MICROSOMAL AMINOPEPTIDASE; PLACEBO; THY 1 ANTIGEN; VASCULOTROPIN 165;

ABDOMINAL FAT; ADIPOSE DERIVED STEM CELL; ADIPOSE DERIVED STEM CELL TRANSPLANTATION; ANGINA PECTORIS; ANGIOGENESIS; ANTIGEN EXPRESSION; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL ISOLATION; CELL STIMULATION; CELL SURFACE; COMPUTER ASSISTED TOMOGRAPHY; ENDOTHELIUM CELL; EXERCISE TOLERANCE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART MUSCLE BLOOD FLOW; HEART MUSCLE CELL; HUMAN; ISCHEMIC HEART DISEASE; LIPOSUCTION; METHODOLOGY; MULTIPOTENT STEM CELL; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHASE 2 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); STEM CELL EXPANSION; STEM CELL TRANSPLANTATION; TISSUE REGENERATION; TREATMENT OUTCOME;

ADIPOSE TISSUE; ANIMALS; CHRONIC DISEASE; CLINICAL TRIALS AS TOPIC; HUMANS; MESENCHYMAL STROMAL CELLS; MYOCARDIAL ISCHEMIA; RESEARCH DESIGN;

EID: 84861316692     PISSN: 17460751     EISSN: 1746076X     Source Type: Journal    
DOI: 10.2217/rme.12.17     Document Type: Article

References (40)

1. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 367(9524), 1747-1757 (2006).
2. Kastrup J. Stem cell therapy for cardiovascular repair in ischemic heart disease: how to predict and secure optimal outcome? EPMA J. 2(1), 107-117 (2011).
3. Mathiasen AB, Haack-Sørensen M, Kastrup J. Mesenchymal stromal cells for cardiovascular repair: current status and future challenges. Future Cardiol. 5(6), 605-617 (2009).
4. Lin CS, Xin ZC, Deng CH, Ning H, Lin G, Lue TF. Defining adipose tissue-derived stem cells in tissue and in culture. Histol. Histopathol. 25(6), 807-815 (2010).
5. Zuk PA, Zhu M, Mizuno H et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 7(2), 211-228 (2001).
6. Strem BM, Hicok KC, Zhu M et al. Multipotential differentiation of adipose tissue-derived stem cells. Keio J. Med. 54(3), 132-141 (2005).
7. Helder MN, Knippenberg M, Klein-Nulend J, Wuisman PI. Stem cells from adipose tissue allow challenging new concepts for regenerative medicine. Tissue Eng. 13(8), 1799-1808 (2007).
8. Bochev I, Elmadjian G, Kyurkchiev D et al. Mesenchymal stem cells from human bone marrow or adipose tissue differently modulate mitogen-stimulated B-cell immunoglobulin production in vitro. Cell Biol. Int. 32(4), 384-393 (2008).
9. Fraser JK, Schreiber R, Strem B et al. Plasticity of human adipose stem cells toward endothelial cells and cardiomyocytes. Nat. Clin. Pract. Cardiovasc. Med. 3(Suppl. 1), S33-S37 (2006).
10. Heydarkhan-Hagvall S, Schenke-Layland K, Yang JQ et al. Human adipose stem cells: a potential cell source for cardiovascular tissue engineering. Cells Tissues Organs 187(4), 263-274 (2008).
11. Lin K, Matsubara Y, Masuda Y et al. Characterization of adipose tissue-derived cells isolated with the Celution system. Cytotherapy 10(4), 417-426 (2008).
12. Katz AJ, Tholpady A, Tholpady SS, Shang H, Ogle RC. Cell surface and transcriptional characterization of human adipose-derived adherent stromal (hADAS) cells. Stem Cells 23(3), 412-423 (2005).
13. Zuk PA, Zhu M, Ashjian P et al. Human adipose tissue is a source of multipotent stem cells. Mol. Biol. Cell 13(12), 4279-4295 (2002).
14. Gronthos S, Franklin DM, Leddy HA, Robey PG, Storms RW, Gimble JM. Surface protein characterization of human adipose tissue-derived stromal cells. J. Cell. Physiol. 189(1), 54-63 (2001).
15. Mitchell JB, McIntosh K, Zvonic S et al. Immunophenotype of human adipose-derived cells: temporal changes in stromal-associatedand stem cell-associated markers. Stem Cells 24(2), 376-385 (2006).
16. Huang JI, Zuk PA, Jones NF et al. Chondrogenic potential of multipotential cells from human adipose tissue. Plast. Reconstr. Surg. 113(2), 585-594 (2004).
17. Weinzierl K, Hemprich A, Frerich B. Bone engineering with adipose tissue derived stromal cells. J. Craniomaxillofac. Surg. 34(8), 466-471 (2006).
18. Safford KM, Hicok KC, Safford SD et al. Neurogenic differentiation of murine and human adipose-derived stromal cells. Biochem. Biophys. Res. Commun. 294(2), 371-379 (2002).
19. Stock P, Staege MS, Muller LP et al. Hepatocytes derived from adult stem cells. Transplant. Proc. 40(2), 620-623 (2008).
20. Wang C, Yin S, Cen L et al. Differentiation of adipose-derived stem cells into contractile smooth muscle cells induced by transforming growth factor-beta1 and bone morphogenetic protein-4. Tissue Eng. Part A 16(4), 1201-1213 (2010).
21. Planat-Benard V, Silvestre JS, Cousin B et al. Plasticity of human adipose lineage cells toward endothelial cells: physiological and therapeutic perspectives. Circulation 109(5), 656-663 (2004).
22. Planat-Benard V, Menard C, Andre M et al. Spontaneous cardiomyocyte differentiation from adipose tissue stroma cells. Circ. Res. 94(2), 223-229 (2004).
23. Strem BM, Zhu M, Alfonso Z et al. Expression of cardiomyocytic markers on adipose tissue-derived cells in a murine model of acute myocardial injury. Cytotherapy 7(3), 282-291 (2005).
24. Valina C, Pinkernell K, Song YH et al. Intracoronary administration of autologous adipose tissue-derived stem cells improves left ventricular function, perfusion, and remodelling after acute myocardial infarction. Eur. Heart J. 28(21), 2667-2677 (2007).
25. Mazo M, Planat-Benard V, Abizanda G et al. Transplantation of adipose derived stromal cells is associated with functional improvement in a rat model of chronic myocardial infarction. Eur. J. Heart Fail. 10(5), 454-462 (2008).
26. Wang L, Deng J, Tian W et al. Adipose-derived stem cells are an effective cell candidate for treatment of heart failure: an MR imaging study of rat hearts. Am. J. Physiol. Heart Circ. Physiol. 297(3), H1020-H1031 (2009).
27. Ii M, Horii M, Yokoyama A et al. Synergistic effect of adipose-derived stem cell therapy and bone marrow progenitor recruitment in ischemic heart. Lab. Invest. 91(4), 539-552 (2011).
28. Rasmussen JG, Frobert O, Pilgaard L et al. Prolonged hypoxic culture and trypsinization increase the pro-angiogenic potential of human adipose tissue-derived stem cells. Cytotherapy 13(3), 318-328 (2011).
29. Haack-Sørensen M, Friis T, Bindslev L, Mortensen S, Johnsen HE, Kastrup J. Comparison of different culture conditions for human mesenchymal stromal cells for clinical stem cell therapy. Scand. J. Clin. Lab. Invest. 68(3), 192-203 (2008).
30. Baldazzi F, Jorgensen E, Ripa RS, Kastrup J. Release of biomarkers of myocardial damage after direct intramyocardial injection of genes and stem cells via the percutaneous transluminal route. Eur. Heart J. 29(15), 1819-1826 (2008).
31. Kastrup J, Jorgensen E, Ruck A et al. Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris A randomized double-blind placebo-controlled study: the Euroinject One trial. J. Am. Coll. Cardiol. 45(7), 982-988 (2005).
32. Ripa RS, Wang Y, Jorgensen E, Johnsen HE, Hesse B, Kastrup J. Intramyocardial injection of vascular endothelial growth factor-A165 plasmid followed by granulocyte-colony stimulating factor to induce angiogenesis in patients with severe chronic ischaemic heart disease. Eur. Heart J. 27(15), 1785-1792 (2006).
33. Perin E, Fernández-Aviles F. Freshly adipose-derived stem cells in chronic ischaemia. The PRECISE Trial. Presented at: 7th International Symposium on Stem Cell Therapy and Cardiovascular Innovation. Madrid, Spain, 7 May 2010.
34. Duckers E. Freshly adipose-derived stem cells in acute myocardial infartion. The APOLLO Trial. Presented at: 7th International Symposium on Stem Cell Therapy and Cardiovascular Innovation. Madrid, Spain, 7 May 2010.
35. + cell therapy for refractory angina. Circ. Res. 109(4), 428-436 (2011).
36. Friis T, Haack-Sørensen M, Mathiasen AB et al. Mesenchymal stromal cell derived endothelial progenitor treatment in patients with refractory angina. Scand. Cardiovasc. J. 45(3), 161-168 (2011).
37. Haack-Sørensen M, Friis T, Mathiasen AB et al. Direct intramyocardial mesenchymal stromal cell injections in patients with severe refractory angina - one year follow-up. Cell Transplant. (2012) (In Press).
38. Friis T, Haack-Sørensen M, Hansen SK, Hansen L, Bindslev L, Kastrup J. Comparison of mesenchymal stromal cells from young healthy donors and patients with severe chronic coronary artery disease. Scand. J. Clin. Lab. Invest. 71(3), 193-202 (2011).
39. Manchanda A, Aggarwal A, Aggarwal N, Soran O. Management of refractory angina pectoris. Cardiol. J. 18(4), 343-351 (2011).
40. Kastrup J. Gene therapy and angiogenesis in patients with coronary artery disease. Expert Rev. Cardiovasc. Ther. 8(8), 1127-1138 (2010).